Nuclear model analysis of excitation functions of α-particle induced reactions on In and Cd up to 60 MeV with relevance to the production of high specific activity 117m Sn

Aslam, Muhammad; Zubia, K.; Qaim, S.M.

doi:10.1016/j.apradiso.2017.12.002

Cited by 9 publications

(3 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(Table 1) compared with emergent therapeutic radionuclides (such as 67 Cu, 47 Sc, 223 Ra, 166 Ho, 161 Tb, 149 Tb, 212 Pb, 212 Bi, 225 Ac, 213 Bi, 211 At, etc.) (Table 2) [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28]. The great effort that researchers have put in this particular therapeutic field of nuclear medicine is comparable with the research that has been carried out in the last 10 years on Tc-99m alternative production methods [29,30].…”

Section: Introductionmentioning

confidence: 99%

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

et al. 2019

View full text Add to dashboard Cite

Academic journals have published a large number of papers in the therapeutic nuclear medicine (NM) research field in the last 10 years. Despite this, a literature analysis has never before been made to point out the research interest in therapeutic radionuclides (RNs). For this reason, the present study aims specifically to analyze the research output on therapeutic radiometals from 2008 to 2018, with intent to quantify and identify global trends in scientific literature and emphasize the interdisciplinary nature of this research field. The data search targeted conventional (131I, 90Y, 177Lu, 188Re, 186Re, 153Sm, 89Sr, 186Er) and emergent (67Cu, 47Sc, 223Ra, 166Ho, 161Tb, 149Tb, 212Pb/212Bi, 225Ac, 213Bi, 211At, 117mSn) RNs. Starting from this time frame, authors have analyzed and interpreted this scientific trend quantitatively first, and qualitatively after.

show abstract

Section: Introductionmentioning

confidence: 99%

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

et al. 2019

View full text Add to dashboard Cite

show abstract

“…All evaluated data are available on the website of the IAEA [9]. Using theory-aided evaluation, some work has been also carried out outside the abovementioned CRPs (see for example [10][11][12][13][14]). The evaluation efforts have provided reliable standardized data for acceleratorbased radionuclides routinely used in patient care (PET/SPECT imaging and internal radiotherapy), produced either directly or obtained through positron-emitting generator systems 68 Ge/ 68 Ga and 82 Sr/ 82 Rb.…”

Section: Availability and Status Of Standardized Datamentioning

confidence: 99%

“…For production of the β − -emitter 47 Sc (for review see [4]), neither the intermediate energy reaction 48 Ti(p,2p) 47 Sc investigated earlier nor the 51 V(p,αp) 47 Sc process studied recently [34] appears to be successful because of the high level of the radionuclidic impurity 46 Sc. With regard to the conversion electron emitter 117m Sn, the production route 116 Cd(α,3n) 117m Sn was established [11]. Yet, a new measurement suggests that the nuclear process nat Sb(p,xn) 117m Sn over the proton energy range of 30-90 MeV could also be potentially useful [35].…”

Section: Current Nuclear Data Activitiesmentioning

confidence: 99%

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

et al. 2021

View full text Add to dashboard Cite

Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data. The availability of standardized nuclear data for accelerator-based production of medical radionuclides is outlined. Some new directions in radionuclide applications, for example, theranostic approach, bimodal imaging, and radionuclide targeted therapy, are considered and the status of relevant nuclear data is discussed. The current trends in nuclear data research using accelerators are elaborated. The increasing significance of intermediate energy accelerators in production of therapeutic radionuclides is emphasized.

show abstract

New directions in nuclear data research for accelerator-based production of medical radionuclides

Qaim

2024

J Radioanal Nucl Chem

View full text Add to dashboard Cite

Extensive nuclear data studies have been carried out over the last 30 years in the context of accelerator-based production of radionuclides, especially at energies below 30 MeV, and the achieved database is fairly good. Yet there are some deficiencies or new needs of data. Those needs are generally associated with new emerging clinical applications of radionuclides, e.g. theranostic approach, bimodal imaging, radioimmuno-therapy, etc. This article gives an overview of on-going nuclear data research utilizing charged-particle accelerators in four directions, namely low-energy region, intermediate energy range, use of the α-particle beam, and utilization of fast neutrons generated at accelerators. Wherever possible, a comparison of experimental data with theoretical estimates is presented and evaluated (standardised) data, if available, are also briefly discussed.

show abstract

Nuclear model analysis of excitation functions of α-particle induced reactions on In and Cd up to 60 MeV with relevance to the production of high specific activity 117m Sn

Cited by 9 publications

References 37 publications

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

New directions in nuclear data research for accelerator-based production of medical radionuclides

Contact Info

Product

Resources

About